DaVita
DVA
#1730
Rank
S$15.90 B
Marketcap
S$247.87
Share price
-0.01%
Change (1 day)
39.52%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): S$14.10

According to DaVita's latest financial reports the company's current EPS (TTM) is S$14.19. In 2025 the company made an earnings per share (EPS) of S$13.05 a decrease over its 2024 EPS that were of S$14.23.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$14.108.04%
2025S$13.05-8.25%
2024S$14.2344.94%
2023S$9.8227.26%
2022S$7.71-35.56%
2021S$11.9744.1%
2020S$8.3119.7%
2019S$6.94540.48%
2018S$1.08-76.07%
2017S$4.53-19.31%
2016S$5.61242.52%
2015S$1.64-62.87%
2014S$4.4113.43%
2013S$3.898.45%
2012S$3.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
S$31.36 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$14.65 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
S$25.09 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.49-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA